Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-02

Clinical Trial Update: Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating SADBE for recurrent herpes labialis (cold sore) completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SADBE

Snippet

Sponsor: Squarex, LLC | Conditions: Herpes Labialis, Cold Sore | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-11-02